Oxomemazine
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.020.906 |
| Chemical and physical data | |
| Formula | C18H22N2O2S |
| Molar mass | 330.45 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
Oxomemazine is an antihistamine and anticholinergic of the phenothiazine chemical class for the treatment of cough.[1][2]
See also
References
- ↑ Pujet JC, Keddad K, Sévenier F, Jolivet-Landreau I (2002). "[Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study)]". Therapie. 57 (5): 457–63. PMID 12611200.
- ↑ Lee SW, Woo CW, Kim JG (December 1994). "Selectivity of oxomemazine for the M1 muscarinic receptors". Archives of Pharmacal Research. 17 (6): 443–51. doi:10.1007/BF02979123. PMID 10319156.
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes |
|
| Ethylenediamines | |
| Tricyclics | |
| Others |
|
| For topical use | |
Histamine receptor modulators | |||||
|---|---|---|---|---|---|
| H1 |
| ||||
| H2 |
| ||||
| H3 |
| ||||
| H4 |
| ||||
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors | |||||
| Classes |
|
|---|---|
| Antidepressants (TCAs and TeCAs) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Others |
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
